Table 3.

Univariate and multivariate predictors of new onset atrial fibrillation (NOAF) in hospitalized patients with COVID-19.

	Unadjusted OR	95% CI	p value	Adjusted OR	95% CI	p value
Age, years	1.136	0.999–1.291	0.051	1.135	1.019–1.263	0.020
Hypertension	1.560	0.247–9.835	0.636	–	–	–
Heart Failure	0.728	0.111–4.776	0.741	–	–	–
CURB-65	0.805	0.176–3.681	0.780	–	–	–
Diffuse lung infiltration	12.417	0.928–166.005	0.057	24.443	3.905–152.994	0.001
CHA2DS2-VASc	2.674	1.089–6.561	0.032	2.511	1.182–5.331	0.017
Procalcitonin	1.012	0.888–1.154	0.848	–	–	–
ESR	1.035	1.002–1.069	0.037	1.031	1.003–1.059	0.026
WBC	1.056	0.903–1.236	0.490	–	–	–
CRP	1.013	0.999–1.028	0.064	1.017	1.005–1.029	0.004

CURB-65: Confusion, Urea, Respiratory rate, Blood pressure, age > 65 years.

CHA2DS2-VASc: Congestive heart failure/left ventricular dysfunction, Hypertension, Age (≥ 75 years 2 points), Diabetes. Stroke/transient ischemic attack (2 points), Vascular disease, Sex category.

ESR: Eritrocyte Sedimentation Rate.

WBC: White Blood Cell count.

CRP: C reactive protein.